DatasetName,REXO1_C(370) REXO1_S(3) REXO1_S(415) REXO1_S(616) REXO1_S(719) REXO1_S(914),REXO1_S(287) REXO1_S(289) REXO1_S(338) REXO1_S(358) REXO1_S(422) REXO1_S(456) REXO1_S(459) REXO1_S(499) REXO1_S(610) REXO1_S(794) REXO1_S(910)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,0.5174429316855064
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,0.5027926924603977
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,0.492531389067311
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,,0.518973005344092
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,0.5888210155713548,0.5284738957788632
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.5275797461551666
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.5218993704433603
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,0.5183710454366873
DB2022_Intensity L2,,
TM2022_mock.4h.C,,0.5146395536410153
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5773208412902853,0.5233420620442429
FSO2013_Ratio M/L normalized Rep1___1,,0.5277030746771788
SAS2015_AZD/DMSO_Exp3,,0.5172860696254132
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,0.5089717067713976
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.5422177245589601
WZ2023_Pu_010_30min,0.5906827811209188,0.4995199314160519
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,0.5165680626750879
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,0.5150776093898236
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,0.5138080058014465
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,0.5239321934178328
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,0.5156578892442827
EP2017_Pervanadate R#3 normalized log2 ratio,,0.5089507065674317
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,0.5149016151524657
RB2022_5_PostStrength,,
GF2025_P6_Sph,,0.5167339008677062
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5911838177594207,0.5114899410167125
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,0.518412218775286
WZ2023_Pu_005_10min,0.5913374460814071,0.5112668769891351
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.5022136090728903
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5928723835747666,0.5090358677232666
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,0.5748543598624464,0.5358188778725421
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,0.5149698749405602
CR2017_Ratio Replicate 1.4,0.5913299733587346,0.511657803730304
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,,0.5015313186744715
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,0.6025858122523641,0.4998239181259929
FSO2013_Ratio H/L normalized Rep1___1,,0.48128267937244845
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,0.515669645376159
HS2024_3_B_N1,0.5773631894452685,0.522839370881917
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.589358805935778,0.5055839915230899
CK2022_11 40-1,,0.5039932775951371
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.518575889447777
FSO2013_Ratio H/L normalized Rep2,,0.5213149931670662
WZ2023_Pu_005_20min,0.5910171828291356,0.4953073178957617
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5797479007300236,0.5010642130295653
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.6002734028202571,0.5047880121731283
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.6000420234828011,0.5081993121766237
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.5985308641743756,0.5218446176763334
FSO2013_Ratio M/L normalized Rep3___2,,0.5121617142630991
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,0.5126233581863832
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.5883198645832685,0.53561148300376
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,,0.5078738324372466
PG2020_Intensity Mock_10h_D,,0.4840751660282804
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.6055155463598193,0.526398896080562
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.5085565158119656
RCJD2014_5min_1,,0.49805173990133245
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,0.5145705496233485
SAS2015_PLX/AZD_Exp2,,0.5239468320480959
CR2017_Ratio Replicate 3.3,0.575561166717544,0.5182382255213404
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,,0.5140796156766799
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.5928778165869582,0.519063240703455
RN2012_L11,,0.5171134198208646
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,0.5096977796936871
AH2018_LFQ_M_2_C,,
CK2022_3 40-1,,0.5022987273014746
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5801619447845905,0.5249031690628982
YA2020_Reporter_intensity_Cancer_No.5,,0.5147416474194243
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.5805754658662045,0.5181851283285013
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,,0.5135274078958966
HS2024_3_B_T1,0.5973782804855807,0.5205149152796421
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,0.5043376811543044
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,,0.522133151964349
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.5209330215316577
HS2024_8_I_T3,,0.5119355428786289
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.6100358005237956,0.5226738180889557
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5919413074154858,0.5091795657423185
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.49991076835528925
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.6032755468594279,0.511271638255618
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,,0.5201077594044548
RAM2015_Log2 A,,
HS2024_8_PD_T1,,0.5112806635184634
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,,0.5158031712973604
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,0.6072537190223666,0.5022500184743031
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.5839680093982061,0.5458867880222514
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,0.5192825508506984
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.5429286915364215
HS2024_6_B_N1,0.5773041713105393,0.5201032423239694
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.5923823202418083,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.4874294410953446
FSO2013_Ratio M/L normalized Rep2,,0.5301649603931516
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,0.505077245250026
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,,0.5104308459139659
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,
EJN2021_4_Rest_Ins,,
RN2012_H05,,0.5257165226727285
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.5214509268340022
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.6008382452190931,0.5144442462925888
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,
JW2021_After_3,,
GF2025_P8_Sph,,0.5262921786991029
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,
CK2022_11 200-1,,0.5112253313926204
CK2022_12 200-1,,0.5146511246333253
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5730587132121873,
WZ2023_Su_010_20min,0.589792929495445,0.5021836008457808
AH2018_TMTMS2_2_N,,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,0.5186438974511186
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.5974182566251542,
AH2018_TMTMS3_Pool,,
KS2014_Intensity N4,0.592114024104004,0.5116140037139686
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,0.5037064341981826
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,,0.5126819748960076
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,0.5143515094433483
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,0.501706227693325
GF2025_P1_Sph,,0.5080500135271211
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,0.6126997592110511,0.5106646514521955
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5936561695810231,0.5101512526880954
CF2017_EOC 1,,
CK2022_3 200-1,,0.5081378391949617
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,0.5154713735528662
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,0.5169630375273809
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.6091623708286501,0.5167842665682687
HS2024_5_B_T1,0.6090720605659495,0.5228418715148749
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.5870452459444161,0.506721838237014
RB2022_6_PreStrength,,
CK2022_2 40-1,,0.5008219932548806
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.5070755200586822
JW2021_Before_2,,
TM2022_S2.12h.A,,0.5136746585838027
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,,0.5167218064692821
HS2024_4_B_T1,0.5668391818572057,0.5171819226867503
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,0.5099091592630344
CR2017_Ratio Replicate 3.2,0.5633854258521412,0.5203164480750979
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.5368941840051477
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,0.5088246192895439
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.511494357482407
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,0.5044729856502811
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.592362302467483,0.490691204778039
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,0.5183900993560223
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,0.600401449265388,0.5296823642796931
AH2018_TMTMS3_3_X,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,0.5172037452096413
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,0.5126276437211879
AH2018_SILAC_M_1_N,,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,0.5127435572246831
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,0.5209717190487594
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,0.5168118556321206
KBE2022_Log2_Ex_8_U,,0.5160936983848352
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.6056582734319352,0.5369365362935338
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.6070835238543918,0.5234216967202725
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5312162259792076
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.5033545125533964
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,0.510417659557226
LY2019_P3+,,
HH2022_Reporter intensity 6,0.5709840766504822,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,
GF2025_P3_Adh,,0.5073076856616975
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,,
RM2024_Intensity D0-1___2,,0.5082070027279508
LY2019_P4+,,
KBE2022_Log2_Ex_19_U,,0.5166813004760102
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,0.517209090611111
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,0.5113620162861752
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,0.5145644331515276
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5284748068324033
LG2023_Control-2_intensity,,0.5064590934634576
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,0.5109727722299865
HS2024_8_B_T2,0.5882334121203545,0.5102867851607145
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,0.4921275852680724
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5858994828729379,0.5048130230833346
HH2022_Reporter intensity 1,0.6010402399224045,0.5142001021483289
HH2022_Reporter intensity 2,0.6014539879818961,0.514194912623303
RM2024_Intensity D6-2___2,,0.5163309749548977
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,0.5147315521496826
YA2020_Reporter_intensity_Normal_No.5,,0.5134727750514986
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.5809409332094625,0.504022778144411
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,0.5508743003603553
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,0.5098645054434645
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.5200859896997806
AR2021_KD 72h,,0.49609417816360435
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,,0.5161903001140663
RM2024_Intensity D0-3,,0.5069294363026654
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.48080258403892445
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.5977852964854855,0.5183020429790374
PG2020_Intensity 10h_A,,
RN2012_L12,,0.512173442190225
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,,0.5170525111656883
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5317344194776972
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,0.5307218859859922
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.49904735799871797
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,0.5147715860078809
RN2012_L15,,0.5157321750272834
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,0.5142524188625709
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,0.507581981198211
TM2022_mock.4h.B,,0.5149118896904291
KBE2022_Log2_Ex_24_U,,0.5187943124261211
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.5244587311297845
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.6078644151184519,0.5157841307622426
CK2022_7 200-1,,0.5073616267925352
CK2022_5 200-1,,0.507324217904799
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.5201002930442868
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,0.509579700300258
KBE2022_Log2_Ex_25_U,,0.5202484486982647
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.5316860342754764
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,0.5138573660100119
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,,0.5390028728649823
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,0.5064459069239569
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.6013333569672933,0.524878523487212
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,,
AH2018_SILAC_IT_1_X,,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.6103399381832049,0.5057255928427858
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.5250358320767279
WZ2023_Pe_025_20min,0.5887669545257875,0.5097463558350775
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,0.6002086814842318,0.5303935201232618
AH2018_TMTMS2_3_N,,
RN2012_H06,,0.5105799475082043
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.5918898529484956,0.5431787577399494
WZ2023_Su_005_30min,0.5894566938798511,0.5047901405755035
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.5362415723801399
WZ2023_Su_025_10min,0.5890375659578493,0.5063984097697178
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,0.5104999134550101
WZ2023_Su_005_20min,0.5920335337081727,0.4932804364488289
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,0.5067255173829669
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5888639362518472,0.5197207872259556
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,,0.4578060841657603
RN2012_L10,,
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,,0.4971519734535887
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,0.518255529300291
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,
HS2024_4_B_T3,0.580363598007461,0.5418401661622849
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.5753034903659087,0.526590435328274
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.5875654317784272,0.5230454511134733
KBE2022_Log2_Ex_6_U,,0.5185696294566376
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,0.5321567314870421
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.5128341646210529
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.5043464329900131
GF2025_P9_Sph,,0.5151447319562714
CK2022_6 200-1,,0.5068150616127943
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.5975585474047774,0.5101008237652237
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.5835324683939817,0.5449297881610743
SAS2015_AZD/DMSO_Exp1,,0.5153146384412378
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,0.5871747696593016,0.5119081410295214
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,,0.5059005485600484
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.5067646375097405
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5803123009562524,0.5239845195863017
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,0.5145873533300889
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.4975578119283257
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,0.5116139199577421
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5913834359381452,0.5078789990227105
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,0.6080496832078569,0.5130905639514632
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.5967542143253057,0.5362129740780504
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,0.5110728115938931
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,,0.5018761558196725
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,0.5158028898547135
EP2017_Untreated R#3 log2 ratio,,0.5066567085410755
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5737672162704928,0.5213447969063304
HS2024_8_PD_T2,,0.49926615267456387
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,0.5016924415779006
HS2024_8_B_N1,0.5880220734445997,0.531324759097131
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,0.5201795430627821
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,0.5500270426706217
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,0.5039289750795783
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.5149669817793963
YA2020_Reporter_intensity_Normal_No.2,,0.5136421552032853
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.5793160064066881,0.5386037006946984
HS2024_3_PD_T3,0.5969995611873474,0.5457497137921631
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,0.516884545510326
CK2022_2 16-1,,
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,0.5150914550003708
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.6006631940705379,0.5338629649712237
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.565915485925154,0.5249935153913408
PG2020_Intensity Mock_10h_B,,0.4942396931145128
WZ2023_Su_025_30min,0.5914561392548188,0.5072351341094099
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,,0.5074304032927273
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.5930132130293634,0.538061826026373
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.5206477837085203
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,0.5129177033683062
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,0.518980804580806
RM2024_Intensity D0-1,,0.5119791062049814
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.5368614068367599
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,0.5142329389163414
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.5711725769265803,0.5246916655099849
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,0.5188831507783032
GF2025_P3_Sph,,0.5097976712745662
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,0.5180561497296811
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.5891849243824507,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5794187947350361,0.5177817073225943
ZQ2022_N1,,
LY2019_P6-,,
RM2024_Intensity D2-3,,0.5124918166509925
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,0.5051812076532938
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5162189430532341
AH2018_LFQ_3_N,,
RKK2015_TNF-α/IKKb,,0.5123990036172881
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,0.5195212064610991
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,0.4995511929482792
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,0.5068408556753007
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.5790514200361879,0.5267043858333676
WZ2023_Su_025_20min,0.5899635637436819,0.4964967700676422
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.48065468137134154
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.503275225545648
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.5958721002170075,0.5463655644589012
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,,0.5166426720952845
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,0.5277790849899943
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,0.5197539675622991
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.5113931432367216
CK2022_6 40-1,,0.4990872839431449
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,0.5195029550625881
LY2019_P3-,,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5928190169458625,0.5068145534641256
HS2024_8_PD_T3,,0.4986778029819978
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.592145461690323,0.5021149272226141
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.5281945730108742
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.5903324112138377,0.5243182024497941
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,
HS2024_8_I_N2,0.5758264497559968,0.5274444324373386
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,
LY2019_P8+,,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.6002983619409538,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,0.5166618680453219
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,,
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5922001311336735,0.5058317382630692
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,0.5152237860645476
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.6062206084662299,0.5243409475127926
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.5029432147484919
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,0.6088534368125634,0.5203909671217063
HS2024_6_I_T1,0.606436940974998,0.49172700826156546
HS2024_5_B_T3,,0.505027052322259
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,0.5025349958661063
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5925111696594061,0.5111314525115993
KS2014_Intensity C2,,0.5275295930586572
FSO2013_Ratio H/L normalized Rep1___2,,0.5201452671578007
RM2024_Intensity D2-2,,0.5098215115024362
KBE2022_Log2_Ex_42_T,,0.5196979783231014
CK2022_9 200-1,,0.5097751059132954
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.5090189559174605
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.6054814789024419,0.5074056506716714
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5705257306296437,0.533218701000259
HS2024_3_I_T3,0.6054945178579448,0.5366420259949383
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.5174677954894342
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,0.515308475759199
FSO2013_Ratio H/M normalized Rep3___2,,0.5031178005038137
RM2024_Intensity D6-2,,0.5114216328451682
EP2017_Untreated R#1 log2 ratio,,0.4582502527127208
RKK2015_SC-514/basal,,0.490961445918374
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5919105274756359,0.485556103782748
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,0.4952462671128672
KS2014_Intensity N1,0.5872672485478753,0.5056116688525086
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,0.514852048317107
CR2017_Ratio Replicate 1,,0.5483163770821583
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,0.5148436139097675
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.5061722952212525
HS2024_5_B_N2,0.5987488158519263,0.5352799948052797
HS2024_5_I_N1,0.618694649507068,0.5392942966972754
HS2024_6_I_N1,0.599277679751587,0.5125216501122722
AR2021_KD 48h,,0.5146544524383864
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,0.5067223181691755
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5924843542801881,0.5035280872601202
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,0.5936088140872668,0.49750438005860126
AH2018_LFQ_M_2_X,,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,,0.5120756669428324
RM2024_Intensity D4-1___2,,0.5128350432474936
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,0.5179098064647775
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.5080428767521363
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5906785499988422,0.4961366727417634
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.5011922497268956
HS2024_8_B_T3,0.576506646645757,0.5205788309462339
YA2020_Reporter_intensity_Cancer_No.3,,0.5140792018585841
KBE2022_Log2_Ex_44_U,,0.5178520973404831
WZ2023_Pe_010_20min,0.5935076853395914,0.5090849736662062
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,0.5221344812151594
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,0.5097669182840249
KS2014_Intensity C1,,0.5276556807693965
FSO2013_Ratio H/M normalized Rep3___1,,0.5274054444880786
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,,0.5171382977686331
RM2024_Intensity D0-3___2,,0.5095054381512845
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,0.518288841491624
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5913202525558937,0.4947475500039768
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,
FSO2013_Ratio H/L normalized Rep3___2,,0.5128300662960007
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.575887717700451,0.5391731993479458
GF2025_P8_Adh,,0.5268229834875753
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.5174477543816509
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.5781363754457255,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,0.4952543325723536
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,0.5078714392896543
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,,0.5042534054592381
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.621211411142996,0.5389486272562636
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,0.49193284528155606
TM2022_mock.12h.C,,0.5145968893146974
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.6015290233772478,0.5140663520304654
RM2024_Intensity D2-2___2,,0.5153034688590042
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,
AR2021_L41 1 μM,,0.5019422877897987
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,,0.518010600947651
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,0.4908231817418304
MV2014_Ratio H/M normalized B2___1 (5 min),,0.521548136585476
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.5986382363406827,0.5091799004424362
SAS2015_PLX/DMSO_Exp3,,0.5213319066325295
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.5004010028798536
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,
WZ2023_Pu_025_10min,0.5935232282885029,0.5103028638004103
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,0.5259079927925042
FSO2013_Ratio M/L normalized Rep3___1,,0.520743564698938
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,0.5018823455363047
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.592049333935955,0.5100069752126627
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,,0.5135681588293078
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.5052128636774945
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.505479709510187
AH2018_SILAC_IT_2_C,,
CK2022_5 40-1,,0.49926515629656776
AH2018_LFQ_3_X,,
UK2020_UA_3,,
LY2019_P7-,,
GF2025_P5_Adh,,0.520208803049244
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5437673875219531
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,,0.5059750268907695
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,,0.49182573457613277
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,0.51530721268661
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,
YA2020_Reporter_intensity_Cancer_No.4,,0.5137249502946872
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.5168323767742187
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,0.5199618261279776
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,0.5246378701271367
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,0.5167405024974557
HS2024_8_I_T1,0.5898986914950914,0.5132227839640818
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,0.5119951330513408
AH2018_TMTMS2_1_X,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,0.502973954001024
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,0.594484896887412,0.5111288340567941
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,0.5149391807952008
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,0.5161959783037392
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,0.501795402711442
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,0.5729178558040605,0.5276498018224375
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,0.5161152080544471
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,0.5182343170693566
EP2017_Untreated R#2 normalized log2 ratio,,0.5503454648248294
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,0.5772188523809977,0.5392150135113098
SAS2015_PLX/AZD_Exp3,,0.5105022660853952
EP2017_Pervanadate R#2 log2 ratio,,0.5052994823419547
AS2011_Ratio H/L Normalized RNAi_2_1,,
